The Gross Margin of Vyne Therapeutics Inc (VYNE) is 93.38%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 93.38% |
| 2023-12-31 | 77.31% |
| 2022-12-31 | 93.38% |